Shin Nippon Biomedical Laboratories, Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -33.90% vs 59.44% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -35.80% vs 124.18% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6,429.10",
          "val2": "9,726.90",
          "chgp": "-33.90%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,857.90",
          "val2": "2,532.90",
          "chgp": "-26.65%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "78.20",
          "val2": "54.20",
          "chgp": "44.28%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-4.40",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,196.40",
          "val2": "1,863.60",
          "chgp": "-35.80%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "152.20%",
          "val2": "186.50%",
          "chgp": "-3.43%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 22.55% vs 5.42% in Mar 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is -11.84% vs -8.81% in Mar 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "32,413.80",
          "val2": "26,450.50",
          "chgp": "22.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5,596.30",
          "val2": "6,030.30",
          "chgp": "-7.20%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "202.70",
          "val2": "138.80",
          "chgp": "46.04%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-230.90",
          "val2": "8.30",
          "chgp": "-2,881.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "4,864.60",
          "val2": "5,517.70",
          "chgp": "-11.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.10%",
          "val2": "157.40%",
          "chgp": "-6.53%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

6,429.10

9,726.90

-33.90%

Operating Profit (PBDIT) excl Other Income

1,857.90

2,532.90

-26.65%

Interest

78.20

54.20

44.28%

Exceptional Items

0.00

-4.40

100.00%

Consolidate Net Profit

1,196.40

1,863.60

-35.80%

Operating Profit Margin (Excl OI)

152.20%

186.50%

-3.43%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is -33.90% vs 59.44% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -35.80% vs 124.18% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

32,413.80

26,450.50

22.55%

Operating Profit (PBDIT) excl Other Income

5,596.30

6,030.30

-7.20%

Interest

202.70

138.80

46.04%

Exceptional Items

-230.90

8.30

-2,881.93%

Consolidate Net Profit

4,864.60

5,517.70

-11.84%

Operating Profit Margin (Excl OI)

92.10%

157.40%

-6.53%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is 22.55% vs 5.42% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is -11.84% vs -8.81% in Mar 2024

All Annual Results